等待開盤 09-24 09:30:00 美东时间
-0.965
-9.01%
Needham analyst Gil Blum reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $11 price target.
09-23 18:59
U.S. stocks were higher, with the Nasdaq Composite gaining around 400 points on Thursday. Shares of Vicor Corp (NASDAQ:VICR) rose sharply after the company announced it granted a non-exclusive license to a new OEM licensee with the right to procure Vertical Power Delivery modules by its patents from...
09-17 23:58
礼来公司正在为更广泛地进军女性健康领域奠定基础,正在组建专家团队并在包括骨骼健康和子宫内膜异位症在内的多种疾病中寻找新药。该公司一直在招募科学家从事骨质疏松症和...
09-11 03:56
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
BTIG analyst Kambiz Yazdi maintains Absci (NASDAQ:ABSI) with a Buy and raises the price target from $13 to $16.
09-08 18:16
Absci Corporation, a clinical-stage biopharmaceutical company leveraging generative AI for drug discovery, announced its participation in two upcoming investor conferences: the H.C. Wainwright 28th Annual Global Investment Conference on September 15th and the Morgan Stanley 24th Annual Global Healthcare Conference on September 16th, both in New York. Fireside chats will be live and archived on the company’s investor relations website. Absci focus...
09-01 12:00
Moderna暴涨177%!mRNA癌症疫苗迎来“ChatGPT时刻”?大行密集上调目标价,最快2027年有望商业化;16只港美标的谁会接过下一棒?>>
08-20 18:45
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
BTIG analyst Kambiz Yazdi reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $13 price target.
08-12 17:59
Absci (NASDAQ:ABSI) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is a 12.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $318.000 thousand which mis...
08-12 04:08